Table 1.
AES/GRG5 | TF/non-TF | Interaction domain of TF/non-TF | Interaction domain of AES/GRG5 | Functional effect | Assay | Developmental/physiological effect | Refs |
---|---|---|---|---|---|---|---|
AES | Androgen receptor (AR) | N-terminus (aa. 1-559) | Q domain (aa. 1-129) | ↓AR activity | Y2H, PD,CoIP RA, CFA | n/a | (Yu et al., 2001; Zhang et al., 2010) |
AES | Bit1(non-TF) | n/a | n/a | ↑Cytosolic Bit1-mediated apoptosis | Y2H, CoIP, CFA | Apoptosis | (Jan et al., 2004) |
GRG5 | mSix3, dSo (PD only), mSix6 (PD only) | eh-1 like motif in Six3 domain (aa. 1-183) conserved Phe-88 important | Q domain (1-134) | ↑ mSix3 transcriptional repression | Y2H, PD, RA, ICC, no interaction via CoIP, AFA | Eye development | (Zhu et al., 2002) |
GRG5 | mSix2 | No interaction | No interaction | n/a | PD | n/a | (Zhu et al., 2002) |
AES* | Six3, Six6 | Six domain for Six3 (∼ 1-205) and Six6 (1-127) | Q domain | ↓ TLE-mediated Six3/6 transcriptional repression | Y2H, PD, ISH (me -AES and - Six3/6), AFA | Eye development | (Lopez-Rios et al., 2003) |
AES | mSix2, dOptix | n/a | n/a | n/a | Y2H | n/a | (Lopez-Rios et al., 2003) |
AES | Six1 | n/a | n/a | n/a | Y2H, PD | n/a | (Lopez-Rios et al., 2003) |
AES | mSix4 | No interaction | No interaction | n/a | Y2H | n/a | (Lopez-Rios et al., 2003) |
AES | PRDI-BF1 | aa. 331-398 | Q domain | Full length AES does not affect but truncated AES (ΔGP) inhibits PRDI-BF1- mediated activity | Y2H, PD, RA | n/a | (Ren et al., 1999) |
AES | p65 subunit of NF-κB | Vicinity of p65 transactivation domain (aa. 477-521) | n/a | ↓NF-κB-mediated activity | Y2H, PD, CoIP, RA | n/a | (Tetsuka et al., 2000) |
GRG5* | mOct1 | POU domain | Q domain | Potentially ↑ mOct1 activity | Y2H, PD, RA, | Potential↑ transcription of Gonadotropin releasing hormone | (Rave-Harel et al., 2005) |
GRG5* | mMsx1 | n/a | Q domain | ↓ GRG1-mediated mMsx1 transcriptional repression | Y2H, PD, RA, | Potential↑ transcription of Gonadotropin releasing hormone | (Rave-Harel et al., 2005) |
GRG5*, xAES* | Tcf1, dTCF, xTCF3 | n/a | Q domain (aa. 1-106) | xAES and GRG5 ↑xTcf3 activity | Y2H, PD, ICC, RA, and/or AFA | xAES ↑xTcf3- mediated Xenopus axis duplication | (Roose et al., 1998; Brantjes et al., 2001) |
GRG5, xAES | Lef1, mTcf3, mTcf4 | No interaction | No interaction | n/a | Y2H | n/a | (Roose et al., 1998) |
AES# | Lef1 | n/a | n/a | ↓ Lef1 activity | RA | n/a | (Arce et al., 2009) |
AES*# | Lef1 | n/a | n/a | ↑ Lef1 activity | RA | n/a | (Beagle and Johnson, 2010) |
GRG5* | mRunx2 | Last 141 aa: VWRPY motif dispensable | Q and GP domain | ↑ Runx2 activity | Y2H, CoIP, RA, AFA | Skeletal and growth development | (Wang et al., 2004) |
AES* | PRH | No interaction | No interaction | ↓ TLE1-mediated PRH transcriptional repression | CoIP, RA | n/a | (Swingler et al., 2004) |
GRG5* | mNkx2.2, mNkx6.1 | n/a | n/a | ↓ GRG4-mediated mNkx -2.2 and -6.1 transcriptional repression | RA, AFA, ISH | Endogenous GRG5 not expressed during mNkx- mediated neuronal patterning | (Muhr et al., 2001) |
GRG5 | Hes1 | No interaction | No interaction | Does not affect TLE- mediated Hes1 transcriptional repression | PD, CoIP, RA | n/a | (McLarren et al., 2001) |
AES | LRP6-ICD (Non-TF) | n/a | n/a | LRP6-ICD ↓ AES-mediated LEF-1 activity | Y2H, CoIP, RA | n/a | (Beagle and Johnson, 2010) |
AES* | HDRP (Non-TF) | aa. 178-343 | First 17 aa dispensable | HDRP ↓ AES-mediated apoptosis | Y2H, PD, CoIP, CFA, RA | Apoptosis | (Zhang et al., 2008) |
GRG5# | Pax5 | n/a | n/a | Does not affect TLE- mediated Pax5 transcriptional repression | n/a | (Eberhard et al., 2000) | |
AES*# | rHNF3β | n/a | n/a | ↑ HNF3β activity | RA | n/a | (Wang et al., 2000) |
AES | TFIIE | n/a | n/a | Does not affect basal transcription of recombinant template | PD | n/a | (Yu et al., 2001) |
AES | HDAC -1,-3 | No interaction | No interaction | Y2H (HDAC1) PD (HDAC -1,-3) | (Yu et al., 2001; Zhang et al., 2008) | ||
GRG5 | HDAC1 | No interaction | No interaction | CoIP | (Brantjes et al., 2001) |
Y2H, yeast-two-hybrid; RA, transcriptional reporter assay; PD, pull down; CoIP, co-immunoprecipitation assay; ISH, in situ hybridization; ICC, immunocytochemistry; AFA, functional assay in animal; CFA, cell culture based functional assay; TF/non-TF, Transcription Factor or non-Transcription Factor protein. Unless noted, the identified proteins are TFs. All TF/non-TF proteins are human unless noted and/or not identified by the study. d, Drosophila, me, medaka, x, Xenopus, r, rat, m, mouse.
represent opposing effects between long TLE/GRGs and AES/GRG5 for the identified TF/non-TF protein.
represent possible functional interactions for which interaction assays were not performed. n/a, information not reported or not identified/assayed.